PMID- 31632101 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220410 IS - 1178-6973 (Print) IS - 1178-6973 (Electronic) IS - 1178-6973 (Linking) VI - 12 DP - 2019 TI - Characterization Of The Interaction Between Subviral Particles Of Hepatitis B Virus And Dendritic Cells - In Vitro Study. PG - 3125-3135 LID - 10.2147/IDR.S221294 [doi] AB - BACKGROUND: During an infection with hepatitis B virus (HBV), infectious particles (Dane particles) can be detected in addition to aggregates of the subviral particles (SVP) which is considered an immune escaping mechanism for the virus. Dendritic cells (DCs) are a specialized type of antigen-presenting cell (APC) that can activate native T-cells to prime an immune response controlling HBV infection. The aim of this study was to characterize the interaction between HBVsvp and DCs in vitro. METHODS: HBVsvp that comprises surface and core proteins were produced in vitro by HepG2.2.15 as a culturing system; DCs derived from the bone marrow of mice were pulsed by HBVsvp. A different pattern of cytokines secreted by bone-marrow-derived dendritic cells from C56BL/6 mice pulsed with HBVsvp were analyzed. The interactions between HBVsvp and DCs were characterized using FACS analysis, protein assay, Western blot, and immunofluorescence staining. RESULTS: Pulsation of DCs with HBVsvp resulted in strong activation and higher secretion of DC cytokines including INF-alpha, INF-gamma, TNF-alpha, IL-1alpha, IL-10, and IL-12; but not for IL-1beta, IL-2, IL-6, and IL-15. The production of CXCL-10/IP-10 was increased during the observation period and reached the maximal secretion after 24 hrs (p < 0.001). In total protein assay, we found significantly higher protein concentration in HBVsvp stimulated DC groups compared to not activated DCs (p < 0.001). Both 24 kDa small surface antigen (HBVs) and the 21 kDa core protein (HBVc) were detected in activated DCs. For DCs immunofluorescence staining, our data showed clear differences in the morphology of DCs between negative control and those pulsed with HBVsvp. CONCLUSION: Result demonstrates a significant complex interaction between HBVsvp and DCs, in vitro. CI - (c) 2019 Farag et al. FAU - Farag, Mohamed Ms AU - Farag MM AUID- ORCID: 0000-0003-0581-8576 AD - Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Nasr City, Cairo, Egypt. FAU - Peschel, Georg AU - Peschel G AD - Department of Gastroenterology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, Regensburg 93053, Germany. FAU - Muller, Martina AU - Muller M AD - Department of Gastroenterology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, Regensburg 93053, Germany. FAU - Weigand, Kilian AU - Weigand K AD - Department of Gastroenterology, Endocrinology, Rheumatology and Infectious Diseases, University Hospital Regensburg, Regensburg 93053, Germany. LA - eng PT - Journal Article DEP - 20191007 PL - New Zealand TA - Infect Drug Resist JT - Infection and drug resistance JID - 101550216 PMC - PMC6789970 OTO - NOTNLM OT - cytokines OT - dendritic cell-based therapy OT - hepatitis B virus subviral particles COIS- The authors report no conflicts of interest in this work. EDAT- 2019/10/22 06:00 MHDA- 2019/10/22 06:01 PMCR- 2019/10/07 CRDT- 2019/10/22 06:00 PHST- 2019/06/29 00:00 [received] PHST- 2019/08/28 00:00 [accepted] PHST- 2019/10/22 06:00 [entrez] PHST- 2019/10/22 06:00 [pubmed] PHST- 2019/10/22 06:01 [medline] PHST- 2019/10/07 00:00 [pmc-release] AID - 221294 [pii] AID - 10.2147/IDR.S221294 [doi] PST - epublish SO - Infect Drug Resist. 2019 Oct 7;12:3125-3135. doi: 10.2147/IDR.S221294. eCollection 2019.